NXEN   $0.0235  4.44% Market Closed

Nexien BioPharma Inc
Total Cash 2.62K
totalCashPerShare 0.0
EBITDA
Total Debt 280.45K
quickRatio 0.008
currentRatio 0.008
Total Revenue
debtToEquity
Revenue/Share
ROA -3.30903
ROE
grossProfits
freeCashflow 11.46K
operatingCashflow -66.37K
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 1.65M
forwardPE
floatShares 25.97M
sharesOutstanding 67.47M
sharesShort
sharesShortPriorMonth
dateShortInterest
sharesPercentSharesOut
heldPercentInsiders 0.54%
heldPercentInstitutions 0.0
Short Ratio help_outline
shortPercentOfFloat
impliedSharesOutstanding
bookValue -0.005
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -272.87K
trailingEps -0.01%
forwardEps
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 0
lastUpdated April 1, 2024, 2:12 p.m.